Filana Therapeutics, Inc. FLNA
Set alert
0.56 USD -0.06 -9.81%
At close
0.57 +0.01 +1.59%
Pre-market · Nov 3, 5:10 AM ET
0.56 Day range 0.63
0.56 52-week range 3.45
- YTD
- -71.67%
- 1 year
- -82.41%
- Open
- 0.63
- Prev close
- 0.622
- Mkt cap
- 27.10M
- Vol
- 546.58K
- Avg vol
- 2.02M
- EPS
- -0.87
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.56
- High
- 0.63
YTD chart
Signals (27)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| RSI: Oversold | Sep 11, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 2, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 31, 2026 | 3 months ago |
| RSI: Oversold | Jul 22, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 1, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 12, 2026 | 4 months ago |
| MACD: Buy Signal | May 21, 2026 | 5 months ago |
| RSI: Oversold | May 15, 2026 | 5 months ago |
| RSI: Oversold | May 11, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 15, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 14, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 9, 2026 | 6 months ago |
Newest 20 of 27.
Financials — quick view
FLNA Revenue — quarterly 0
FLNA Net income — quarterly -8.60M
FLNA EPS — quarterly -0.18
News
- Filana Therapeutics Announces A Study Published By Yale Researchers Of New Preclinical Research On Simufilam Examined Simufilam's Impacts In Human Cell Line To Eliminate Tuberous Sclerosis Complex 2 Gene To Model Cellular Changes
- Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells
Your note
Sign in to keep a note on FLNA — it syncs with the Stock Master app.